- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03930160
LODS rolle i forudsigelse af 30-dages dødelighedsudfald på intensivafdeling
Logistisk organdysfunktionssystem Rolle i forudsigelse af 30-dages dødelighedsudfald på intensivafdeling af dr. Cipto Mangunkusumo General Hospital Patienter
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
DKI Jakarta
-
Jakarta Pusat, DKI Jakarta, Indonesien, 10430
- Rumah Sakit Cipto Mangunkusumo
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inklusionskriterier:
- voksen patient (18 år og derover) indlagt på intensivafdeling
Ekskluderingskriterier:
- patienter indlagt på intensivafdeling på grund af forbrændingsskade, koronararteriesygdom, efter hjertekirurgi
- patienter med ufuldstændig påkrævet information for LODS-score
- patienter, der er døde eller udskrevet mindre end 24 timer efter indlæggelsen
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kohorte
- Tidsperspektiver: Tilbagevirkende kraft
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
Dødelighedsudfald
|
Variabler af logistisk organ dysfunktion system score, herunder: GCS; hjerterytme; systolisk BP; blod urinstof; serum kreatinin; urinproduktion; leukocyttal; antal blodplader; Pa02/Fi02; serum bilirubin; protrombintid.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
LODS scorer diskriminationsevne
Tidsramme: 30 dage fra indlæggelse
|
LODS score evne til at skelne patientresultater baseret på variabler af logistiske organ dysfunktion system score: GCS; hjerterytme; systolisk BP; blod urinstof; serum kreatinin; urinproduktion; leukocyttal; antal blodplader; Pa02/Fi02; serum bilirubin; protrombintid.
|
30 dage fra indlæggelse
|
LODS score kalibrering
Tidsramme: 30 dage fra indlæggelse
|
LODS score evne til at forudsige patientresultater baseret på variabler af logistisk organ dysfunktion system score: GCS; hjerterytme; systolisk BP; blod urinstof; serum kreatinin; urinproduktion; leukocyttal; antal blodplader; Pa02/Fi02; serum bilirubin; protrombintid.
|
30 dage fra indlæggelse
|
Korrelation mellem LODS-scorevariabler med patientudfald
Tidsramme: 30 dage fra indlæggelse
|
Korrelation mellem patientresultater med hver LODS-scorevariable: GCS; hjerterytme; systolisk BP; blod urinstof; serum kreatinin; urinproduktion; leukocyttal; antal blodplader; Pa02/Fi02; serum bilirubin; protrombintid.
|
30 dage fra indlæggelse
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Patientudfald
Tidsramme: 30 dage fra indlæggelse
|
Patientudfald inden for 30 dage efter indlæggelse på intensiv afdeling (ICU): død eller overlevede
|
30 dage fra indlæggelse
|
LODS neurologisk variabel score: Glasgow Coma Scale (GCS)
Tidsramme: Dag 1
|
Scoren for GCS variabel cutoff: 0 point for 14-15; 1 point for 9-13; 3 point for 6-8; 5 point for 3-5. |
Dag 1
|
LODS kardiovaskulær variabel score: Hjertefrekvens (HR) og/eller systolisk blodtryk (SBP)
Tidsramme: Dag 1
|
Scoren for HR (i slag/min) og/eller SBP (i mmHg) variabel cutoff: 0 point for HR 30-139 og SBP 90-239; 1 point for SBP 70-89 eller 240-269 eller HR >=140; 3 point for SBP 40-69 eller >=270; 5 point for HR <30 eller SBP <40. |
Dag 1
|
LODS renal variabel score: serum urea nitrogen (BUN) og/eller kreatinin og/eller urinproduktion (UO)
Tidsramme: Dag 1
|
Score for BUN (i mg/dL) og/eller kreatinin (i mg/dL) og/eller UO (i liter/dag) variabel cutoff: 0 point for BUN <17 OG kreatinin <1,20 OG UO 0,75-9,99; 1 point for BUN 17-<28 ELLER kreatinin 1,20-1,59; 3 point for BUN 28-<56 OG kreatinin <1,60 OG UO 0,5-0,74 eller >=10; 5 point for BUN >=56 ELLER UO 0,5. |
Dag 1
|
LODS pulmonal variabel score: Partial ilttryk (PaO2)/fraktion af indåndet ilt (FiO2) på mekanisk ventilation (MV) eller kontinuerligt positivt luftvejstryk (CPAP)
Tidsramme: Dag 1
|
Scoren for PaO2/FiO2 (i mmHg/%) variabel cutoff: 0 point for ingen ventilation og ingen CPAP; 1 point for >=150; 3 point for <150. |
Dag 1
|
LODS hæmatologisk variabel score: antal hvide blodlegemer (WBC) og/eller blodpladetal
Tidsramme: Dag 1
|
Scoren for WBC (i x10^3/L) og/eller blodpladeantal i (x10^3/L) variabel cutoff: 0 point for WBC 2,5-49,9 og blodplade >=50; 1 point for WBC 1,0-2,4 eller >=50,0 ELLER blodplade <50; 3 point til WBC <1,0 |
Dag 1
|
LODS leverfunktion variabel score: Serum bilirubin og/eller protrombintid (PT)
Tidsramme: Dag 1
|
Scoren for serumbilirubin (i mg/dL) og/eller PT (i % af standard) variabel cutoff: 0 point for bilirubin <2,0 og PT >=25; 1 point for bilirubin >=2,0 ELLER PT<25 % eller >3. |
Dag 1
|
Samarbejdspartnere og efterforskere
Sponsor
Publikationer og nyttige links
Generelle publikationer
- Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974 Jul 13;2(7872):81-4. doi: 10.1016/s0140-6736(74)91639-0. No abstract available.
- Power GS, Harrison DA. Why try to predict ICU outcomes? Curr Opin Crit Care. 2014 Oct;20(5):544-9. doi: 10.1097/MCC.0000000000000136.
- Rapsang AG, Shyam DC. Scoring systems in the intensive care unit: A compendium. Indian J Crit Care Med. 2014 Apr;18(4):220-8. doi: 10.4103/0972-5229.130573.
- Purnama Dewi O, Nurfitri E. Pediatric logistic organ dysfunction score as a predictive tool of dengue shock syndrome outcomes. Paediatrica Indonesiana. 2012;52(2):72-77.
- Grenvik A, Ayres SM, Holbrook PR, Shoemaker WC, editors. Textbook of Critical Care. Subsequent edition. Philadelphia: W B Saunders Co; 2000. 2227 p
- Rao SM, Suhasini T. Organization of intensive care unit and predicting outcome of critical illness. Indian J Anaesth. 2003;47(5):328-37.
- Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres D. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA. 1996 Sep 11;276(10):802-10. doi: 10.1001/jama.276.10.802.
- Heldwein MB, Badreldin AM, Doerr F, Lehmann T, Bayer O, Doenst T, Hekmat K. Logistic Organ Dysfunction Score (LODS): a reliable postoperative risk management score also in cardiac surgical patients? J Cardiothorac Surg. 2011 Sep 16;6:110. doi: 10.1186/1749-8090-6-110.
- Kim TK, Yoon JR. Comparison of the predictive power of the LODS and APACHE II scoring systems in a neurological intensive care unit. J Int Med Res. 2012;40(2):777-86. doi: 10.1177/147323001204000244.
- Saranya AVR S. Comparison of Different Scoring Systems Used in the Intensive Care Unit. Journal of Pulmonary & Respiratory Medicine. 2015;05(04).
- Timsit JF, Fosse JP, Troche G, De Lassence A, Alberti C, Garrouste-Orgeas M, Azoulay E, Chevret S, Moine P, Cohen Y. Accuracy of a composite score using daily SAPS II and LOD scores for predicting hospital mortality in ICU patients hospitalized for more than 72 h. Intensive Care Med. 2001 Jun;27(6):1012-21. doi: 10.1007/s001340100961.
- Timsit JF, Fosse JP, Troche G, De Lassence A, Alberti C, Garrouste-Orgeas M, Bornstain C, Adrie C, Cheval C, Chevret S; OUTCOMEREA Study Group, France. Calibration and discrimination by daily Logistic Organ Dysfunction scoring comparatively with daily Sequential Organ Failure Assessment scoring for predicting hospital mortality in critically ill patients. Crit Care Med. 2002 Sep;30(9):2003-13. doi: 10.1097/00003246-200209000-00009.
- Bouch DC, Thompson JP. Severity scoring systems in the critically ill. Contin Educ Anaesth Crit Care Pain. 2008;8:181-5.
- Dolejs J, Maresova P. Onset of mortality increase with age and age trajectories of mortality from all diseases in the four Nordic countries. Clin Interv Aging. 2017 Jan 21;12:161-173. doi: 10.2147/CIA.S119327. eCollection 2017.
- Ingraham AM, Cohen ME, Raval MV, Ko CY, Nathens AB. Comparison of hospital performance in emergency versus elective general surgery operations at 198 hospitals. J Am Coll Surg. 2011 Jan;212(1):20-28.e1. doi: 10.1016/j.jamcollsurg.2010.09.026. Erratum In: J Am Coll Surg. 2011 Jun;212(6):1100-1.
- Ball IM, Bagshaw SM, Burns KE, Cook DJ, Day AG, Dodek PM, Kutsogiannis DJ, Mehta S, Muscedere JG, Turgeon AF, Stelfox HT, Wells GA, Stiell IG. Outcomes of elderly critically ill medical and surgical patients: a multicentre cohort study. Can J Anaesth. 2017 Mar;64(3):260-269. doi: 10.1007/s12630-016-0798-4. Epub 2016 Dec 27.
- De Jong A, Verzilli D, Sebbane M, Monnin M, Belafia F, Cisse M, Conseil M, Carr J, Jung B, Chanques G, Molinari N, Jaber S. Medical Versus Surgical ICU Obese Patient Outcome: A Propensity-Matched Analysis to Resolve Clinical Trial Controversies. Crit Care Med. 2018 Apr;46(4):e294-e301. doi: 10.1097/CCM.0000000000002954.
- Arihan O, Wernly B, Lichtenauer M, Franz M, Kabisch B, Muessig J, Masyuk M, Lauten A, Schulze PC, Hoppe UC, Kelm M, Jung C. Blood Urea Nitrogen (BUN) is independently associated with mortality in critically ill patients admitted to ICU. PLoS One. 2018 Jan 25;13(1):e0191697. doi: 10.1371/journal.pone.0191697. eCollection 2018.
- Hashemian SM, Jamaati H, Farzanegan Bidgoli B, Farrokhi FR, Malekmohammad M, Roozdar S, Mohajerani SA, Bagheri A, Radmnand G, Hatami B, Chitsazan M. Outcome of Acute Kidney Injury in Critical Care Unit, Based on AKI Network. Tanaffos. 2016;15(2):89-95.
- Engoren M, Maile MD, Heung M, Jewell ES, Vahabzadeh C, Haft JW, Kheterpal S. The Association Between Urine Output, Creatinine Elevation, and Death. Ann Thorac Surg. 2017 Apr;103(4):1229-1237. doi: 10.1016/j.athoracsur.2016.07.036. Epub 2016 Oct 4.
- Macedo E, Malhotra R, Bouchard J, Wynn SK, Mehta RL. Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int. 2011 Oct;80(7):760-7. doi: 10.1038/ki.2011.150. Epub 2011 Jun 29.
- Zhang Z, Xu X, Ni H, Deng H. Urine output on ICU entry is associated with hospital mortality in unselected critically ill patients. J Nephrol. 2014 Feb;27(1):65-71. doi: 10.1007/s40620-013-0024-1. Epub 2014 Jan 15.
- Saygitov RT, Glezer MG, Semakina SV. Blood urea nitrogen and creatinine levels at admission for mortality risk assessment in patients with acute coronary syndromes. Emerg Med J. 2010 Feb;27(2):105-9. doi: 10.1136/emj.2008.068155.
- Ting HW, Chen MS, Hsieh YC, Chan CL. Good mortality prediction by Glasgow Coma Scale for neurosurgical patients. J Chin Med Assoc. 2010 Mar;73(3):139-43. doi: 10.1016/S1726-4901(10)70028-9.
- Nik A, Sheikh Andalibi MS, Ehsaei MR, Zarifian A, Ghayoor Karimiani E, Bahadoorkhan G. The Efficacy of Glasgow Coma Scale (GCS) Score and Acute Physiology and Chronic Health Evaluation (APACHE) II for Predicting Hospital Mortality of ICU Patients with Acute Traumatic Brain Injury. Bull Emerg Trauma. 2018 Apr;6(2):141-145. doi: 10.29252/beat-060208.
- Zhang D, Shen X, Qi X. Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis. CMAJ. 2016 Feb 16;188(3):E53-E63. doi: 10.1503/cmaj.150535. Epub 2015 Nov 23.
- Reunanen A, Karjalainen J, Ristola P, Heliovaara M, Knekt P, Aromaa A. Heart rate and mortality. J Intern Med. 2000 Feb;247(2):231-9. doi: 10.1046/j.1365-2796.2000.00602.x.
- Prasada S, Oswalt C, Yeboah P, Saylor G, Bowden D, Yeboah J. Heart rate is an independent predictor of all-cause mortality in individuals with type 2 diabetes: The diabetes heart study. World J Diabetes. 2018 Jan 15;9(1):33-39. doi: 10.4239/wjd.v9.i1.33.
- Tongyoo S, Permpikul C, Haemin R, Epichath N. Predicting factors, incidence and prognosis of cardiac arrhythmia in medical, non-acute coronary syndrome, critically ill patients. J Med Assoc Thai. 2013 Feb;96 Suppl 2:S238-45.
- Li C, Chen Y, Zheng Q, Wu W, Chen Z, Song L, An S, Li Z, Chen S, Wu SL. Relationship between systolic blood pressure and all-cause mortality: a prospective study in a cohort of Chinese adults. BMC Public Health. 2018 Jan 5;18(1):107. doi: 10.1186/s12889-017-4965-5.
- Lv YB, Gao X, Yin ZX, Chen HS, Luo JS, Brasher MS, Kraus VB, Li TT, Zeng Y, Shi XM. Revisiting the association of blood pressure with mortality in oldest old people in China: community based, longitudinal prospective study. BMJ. 2018 Jun 5;361:k2158. doi: 10.1136/bmj.k2158.
- Ruggiero C, Metter EJ, Cherubini A, Maggio M, Sen R, Najjar SS, Windham GB, Ble A, Senin U, Ferrucci L. White blood cell count and mortality in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol. 2007 May 8;49(18):1841-50. doi: 10.1016/j.jacc.2007.01.076. Epub 2007 Apr 23.
- Bonaccio M, Di Castelnuovo A, Costanzo S, De Curtis A, Donati MB, Cerletti C, de Gaetano G, Iacoviello L; MOLI-SANI Investigators. Age-sex-specific ranges of platelet count and all-cause mortality: prospective findings from the MOLI-SANI study. Blood. 2016 Mar 24;127(12):1614-6. doi: 10.1182/blood-2016-01-692814. Epub 2016 Feb 10. No abstract available.
- Tsai MT, Chen YT, Lin CH, Huang TP, Tarng DC; Taiwan Geriatric Kidney Disease Research Group. U-shaped mortality curve associated with platelet count among older people: a community-based cohort study. Blood. 2015 Sep 24;126(13):1633-5. doi: 10.1182/blood-2015-06-654764. Epub 2015 Aug 11. No abstract available.
- van der Bom JG, Heckbert SR, Lumley T, Holmes CE, Cushman M, Folsom AR, Rosendaal FR, Psaty BM. Platelet count and the risk for thrombosis and death in the elderly. J Thromb Haemost. 2009 Mar;7(3):399-405. doi: 10.1111/j.1538-7836.2008.03267.x. Epub 2008 Dec 20.
- Ishizuka M, Tago K, Kubota K. Impact of prothrombin time-International Normalized Ratio on outcome of patients with septic shock receiving polymyxin B cartridge hemoperfusion. Surgery. 2014 Jul;156(1):168-75. doi: 10.1016/j.surg.2014.03.009. Epub 2014 Mar 15.
- Benediktsson S, Frigyesi A, Kander T. Routine coagulation tests on ICU admission are associated with mortality in sepsis: an observational study. Acta Anaesthesiol Scand. 2017 Aug;61(7):790-796. doi: 10.1111/aas.12918.
- Yokoyama Y, Ebata T, Igami T, Sugawara G, Ando M, Nagino M. Predictive power of prothrombin time and serum total bilirubin for postoperative mortality after major hepatectomy with extrahepatic bile duct resection. Surgery. 2014 Mar;155(3):504-11. doi: 10.1016/j.surg.2013.08.022. Epub 2013 Nov 25.
- Pierrakos C, Velissaris D, Felleiter P, Antonelli M, Vanhems P, Sakr Y, Vincent JL; EPIC II investigators. Increased mortality in critically ill patients with mild or moderate hyperbilirubinemia. J Crit Care. 2017 Aug;40:31-35. doi: 10.1016/j.jcrc.2017.01.017. Epub 2017 Feb 13.
- Su HH, Kao CM, Lin YC, Lin YC, Kao CC, Chen HH, Hsu CC, Chen KC, Peng CC, Wu MS. Relationship between serum total bilirubin levels and mortality in uremia patients undergoing long-term hemodialysis: A nationwide cohort study. Atherosclerosis. 2017 Oct;265:155-161. doi: 10.1016/j.atherosclerosis.2017.09.001. Epub 2017 Sep 4.
- Yang TL, Lin YC, Lin YC, Huang CY, Chen HH, Wu MS. Total Bilirubin in Prognosis for Mortality in End-Stage Renal Disease Patients on Peritoneal Dialysis Therapy. J Am Heart Assoc. 2017 Dec 23;6(12):e007507. doi: 10.1161/JAHA.117.007507.
- Esteve F, Lopez-Delgado JC, Javierre C, Skaltsa K, Carrio ML, Rodriguez-Castro D, Torrado H, Farrero E, Diaz-Prieto A, Ventura JL, Manez R. Evaluation of the PaO2/FiO2 ratio after cardiac surgery as a predictor of outcome during hospital stay. BMC Anesthesiol. 2014 Sep 26;14:83. doi: 10.1186/1471-2253-14-83.
- Villar J, Blanco J, del Campo R, Andaluz-Ojeda D, Diaz-Dominguez FJ, Muriel A, Corcoles V, Suarez-Sipmann F, Tarancon C, Gonzalez-Higueras E, Lopez J, Blanch L, Perez-Mendez L, Fernandez RL, Kacmarek RM; Spanish Initiative for Epidemiology, Stratification & Therapies for ARDS (SIESTA) Network. Assessment of PaO(2)/FiO(2) for stratification of patients with moderate and severe acute respiratory distress syndrome. BMJ Open. 2015 Mar 27;5(3):e006812. doi: 10.1136/bmjopen-2014-006812.
- Fialkow L, Farenzena M, Wawrzeniak IC, Brauner JS, Vieira SR, Vigo A, Bozzetti MC. Mechanical ventilation in patients in the intensive care unit of a general university hospital in southern Brazil: an epidemiological study. Clinics (Sao Paulo). 2016 Mar;71(3):144-51. doi: 10.6061/clinics/2016(03)05.
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- IndonesiaUAnes035
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Score for logistisk organdysfunktionssystem
-
Polyak, MaximilianHealth Resources and Services Administration (HRSA)AfsluttetLevertransplantation | Organkonservering